The CLEAR Outcomes Trial
January 8, 2025 | Steven Nissen and C. Michael Gibson discuss using bempedoic acid to reduce MACE in statin-intolerant patients with high cardiovascular risk. |
New at TCTMD? Register today!
Enter the email you used to register to reset your password.